Stockreport

Endocyte Presents Data at the 2017 CAR-TCR Summit Further Demonstrating the Ability to Manage Cytokine Release Syndrome Related to CAR T-Cell Therapy

ENDOCYTE  (ECYT) 
Last endocyte earnings: 11/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.endocyte.com/investor-relations
PDF – Poster further demonstrates the potential of Endocyte’s SMDC CAR-T platform to more safely regulate CAR-T therapy for solid tumors – – Unwanted toxicities may be con [Read more]